uniQure
QURE
#5425
Rank
HK$10.33 B
Marketcap
HK$165.95
Share price
-6.20%
Change (1 day)
192.20%
Change (1 year)

Earnings for uniQure (QURE)

Earnings in 2025 (TTM): -HK$1.76 Billion

According to uniQure's latest financial reports the company's current earnings are HK$15.75 Million. In 2024 the company made an earning of -HK$1.85 Billion, an increase over its 2023 earnings that were of -HK$2.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for uniQure from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.76 Billion-5.14%
2024 -HK$1.85 Billion-22.65%
2023 -HK$2.39 Billion139.01%
2022 -HK$1 Billion-138.54%
2021 HK$2.58 B-335.29%
2020 -HK$1.11 Billion13.88%
2019 -HK$0.97 Billion49.51%
2018 -HK$0.65 Billion4.55%
2017 -HK$0.62 Billion12.65%
2016 -HK$0.55 Billion-9.59%
2015 -HK$0.61 Billion66.95%
2014 -HK$0.37 Billion30.8%
2013 -HK$0.28 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
HK$64.13 B-3,768.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$0.85 Billion-51.49%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
-HK$1.56 Billion-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-HK$4.28 Billion 144.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.79 B-4,149.19%๐Ÿ‡ซ๐Ÿ‡ท France
BioMarin Pharmaceutical
BMRN
HK$5.28 B-402.24%๐Ÿ‡บ๐Ÿ‡ธ USA